In the accompanying slide show, you will find five of the ten low-priced stocks the investment-letter editors are currently recommending.

FORBES: Ten Great Stocks Under $10

In a letter responding to the editors of Pharmacoepidemiology, the study's authors reiterate that including Actos would have reduced the power of their analysis too much.

FORBES: Magazine Article

Already another letter in the same vein was sent to local editors on Aug. 25.

CNN: DEFLECTING RUMORs